We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate Published

News   Feb 04, 2013

 
Data from Historic Phase IIb Clinical Trial for Tuberculosis Vaccine Candidate Published
 
 
 

RELATED ARTICLES

Antidepressant Based on Ketamine Gets Backing from FDA Advisory Group

News

A form of the hallucinogenic party drug ketamine has cleared one of the final hurdles toward clinical use as an antidepressant. During a meeting at the US Food and Drug Administration (FDA) in Silver Spring, Maryland, an independent advisory panel voted 14-2 in favor of recommending a compound known as esketamine for use in treating depression.

READ MORE

Insights on the Role of Estrogen in Type 2 Diabetes

News

This study provides insights into the mechanism by which estrogen can decrease insulin resistance and the production of glucose, reducing incidences of Type 2 diabetes mellitus.

READ MORE

Imaging Agent Could Help Measure Effectiveness of Breast Cancer Therapy Earlier

News

Researchers report that positron emission tomography (PET) imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) has been found to successfully measure changes in progesterone receptor levels resulting from a short-course estrogen treatment, also known as an estradiol challenge.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE